drugset / Trial / NCT02547727
Immune Responses After a Four-site Intradermal Rabies Booster Vaccination in HIV-infected Adults
RandomizedParallel-groupOpen-labelTreatment
Summary
A four-site intradermal rabies booster vaccination in HIV - infected patients who have ever received primary rabies vaccination could improve their immune response to this kind of vaccine.
Timeline
- Start
- 2016-02
- Primary completion
- 2023-12
- Completion
- 2023-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rabies vaccine | Vaccine | 0.1 ml | Intramuscular |
| Subject | Rabies vaccine | Vaccine | 0.5 ml | Intramuscular |